Trial intelligence / Profile preview

ctDNA Biomarkers in Lymphoma Diagnosis and Management

NCT04417803Recruiting

Sponsor
Centre Hospitalier Universitaire Dijon Bourgogne
Start
May 2021
Primary completion
May 2046
Countries
1
01

Overview

Trial (5 arms), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoint: Circulating Tumor DNA Biomarkers at 7 years. Started May 2021; status: recruiting.

Beyond the preview

Go deeper on NCT04417803.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04417803.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call